Psychedelics Summit


Doug Drysdale

Cybin Corp

Doug Drysdale, CEO of Cybin Inc- A leading biotechnology company focused on progressing psychedelic therapeutics to treat psychiatric disorders utilizing proprietary drug discovery platforms, innovative delivery systems, and novel formulations and treatment regiments. Doug Drysldale has chaired the Board of a NASDAQ-listed company and, as CEO for the past 12 years, has built and turned-around 3 pharmaceutical companies. During Doug’s 30 years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 15 corporate acquisitions across three continents and has raised $4 billion of both public and private capital. Doug Drysdale holds a bachelor’s degree in Microbial and Molecular Biology from the University of East Anglia in the United Kingdom and was recognized as Entrepreneur of the Year by Ernst and Young in 2012.